Marshall Wace
CPIX icon

Marshall Wace’s Cumberland Pharmaceuticals CPIX Stock Holding History

Marshall Wace’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,137
Closed -$192K – 3271
2025
Q4 		$192K Buy
+48,137
New +$143K ﹤0.01% 2605
2022
Q1 		– Sell
-79,836
Closed -$373K – 3437
2021
Q4 		$373K Buy
+79,836
New +$272K ﹤0.01% 2951

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Marshall Wace's CPIX Position: Q1 2026 in Review

Marshall Wace sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2026, closing a stake of 48,137 shares — an estimated $192K sold.

Marshall Wace first reported a position in CPIX in Q4 2021 and held it in 2 quarters. The position peaked at $373K in Q4 2021. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Marshall Wace reported no remaining Cumberland Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 48,137 Cumberland Pharmaceuticals shares in Q1 2026, an estimated $192K.
  • Marshall Wace first reported a position in Cumberland Pharmaceuticals in Q4 2021 and held it in 2 quarters.
  • Marshall Wace's Cumberland Pharmaceuticals position peaked at $373K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.